preCharge News BUSINESS — Swiss pharmaceutical giant Novartis beat profit expectations for the second quarter and announced the start of a $10 billion share buyback programme.

The company’s net income grew 26%, excluding changes in currency fluctuations, to $4.02 billion for the second quarter of 2025. Analysts had expected $3.72 billion, according to FactSet.

Novartis also raised its full-year core operating income from the previously guided “low double-digit” to “low teens.”

The company announced plans to return $10 billion to investors through a share buyback programme that is expected to be completed by 2027.

“Our robust balance sheet and confidence in our mid and long-term growth enable us to initiate an up-to USD 10 billion share buyback as part of our commitment to balanced capital allocation,” said Vas Narasimhan, CEO of Novartis.

The stock is up 7.2% year-to-date.

Want to earn some extra money on the side? Buy PCPi Coin or Subscribe to VIP and get dividens monthly.

____
Associated Press, CNBC News, Fox News, and preCharge News contributed to this report.